Please check your internet connection and try again.
# Folic Acid
## Overview
Folic acid (vitamin B9) is a water-soluble B vitamin essential for DNA synthesis, repair, and erythropoiesis. It is a synthetic form of folate used as a supplement or therapeutic agent for deficiency states and the prevention of congenital anomalies.
## Primary Indications
* Treatment and prophylaxis of folate-deficiency megaloblastic anemia.
* Prevention of neural tube defects (NTDs) in pregnancy.
* Supplementation during chronic methotrexate or sulfonamide therapy.
* Hyperhomocysteinemia management (adjunctive).
## Adult Dosing
* **Folate Deficiency:** 1 mg daily. Severe cases may require up to 5 mg daily.
* **Prophylaxis (Pregnancy/High Risk):** 400 mcg to 800 mcg daily.
* **Preventing Methotrexate Toxicity:** 1 mg to 5 mg daily (non-MTX days) or as directed by institutional protocols for chemotherapy adjuncts.
* **Maximum Dose:** Generally 5 mg/day, unless otherwise directed for specific hematologic or metabolic disorders.
## Pediatric Dosing
* **Deficiency (Infants):** 0.1 mg daily.
* **Deficiency (Children 1–12 years):** 0.2 mg to 0.4 mg daily.
* **Maintenance:** 0.1 mg to 0.4 mg daily depending on clinical need (e.g., chronic hemolytic anemia).
* *Note: Dosing should be individualized based on clinical status and dietary intake.*
## Dose Adjustments
* **Renal/Hepatic Impairment:** No standard dose reduction required.
* **Dialysis:** Supplemental doses may be required due to dialysis-related clearance.
## Contraindications
* Known hypersensitivity to folic acid.
* **Crucial Warning:** Folic acid must **not** be used as the sole treatment for pernicious anemia (Vitamin B12 deficiency) or other B12-deficiency anemias. It may correct the hematologic markers of B12 deficiency while allowing irreversible neurological damage to progress.
## Adverse Effects
* Generally well-tolerated.
* Rare: Allergic reactions (rash, pruritus, bronchospasm), nausea, abdominal distension, or flatulence.
## Key Drug Interactions
* **Methotrexate:** Folic acid may decrease the efficacy of low-dose methotrexate used for rheumatoid arthritis or psoriasis (timing of administration is critical).
* **Anticonvulsants (Phenytoin, Carbamazepine, Valproate):** Folic acid may decrease serum concentrations of these drugs via increased hepatic metabolism.
* **Sulfonamides/Pyrimethamine:** May interfere with folate absorption or metabolism.
## Monitoring
* **Hematology:** Monitor CBC, mean corpuscular volume (MCV), and reticulocyte count to evaluate response to treatment.
* **B12 Status:** Ensure Vitamin B12 levels are sufficient before initiating long-term high-dose folic acid to prevent masking symptomatic B12 deficiency.
## Clinical Pearls
* Therapeutic efficacy for megaloblastic anemia is typically seen within 2–4 weeks; symptoms and laboratory markers should improve.
* Folic acid is highly susceptible to degradation by light and heat; store in a cool, dark place.
* Patients with malabsorption syndromes (e.g., celiac disease, Crohn's) may require higher or parenteral dosing.
* Always confirm Vitamin B12 status when megaloblastic anemia is suspected.
***
**Disclaimer:** This information is for educational purposes only. Clinical dosing and protocols may vary based on local guidelines and specific patient populations. Always verify current prescribing information through official resources (e.g., package inserts, Lexicomp, or UpToDate) before administering medication.